Monoclonal antibodies against macrophage colony-stimulating factor diminish the number of circulating intermediate and nonclassical (CD14 ++CD16+/CD14+CD16++) monocytes in rheumatoid arthritis patient

Blood

Volumn 119, Issue 22, 2012, Pages 5329-5330

  Korkosz, Mariusz ^a   Bukowska Strakova, Karolina ^b   Sadis, Seth ^c   Grodzicki, Tomasz ^a   Siedlar, Maciej ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; COLONY STIMULATING FACTOR 1; INTERLEUKIN 10; METHOTREXATE; MONOCLONAL ANTIBODY; PD 360324;

ADULT; CASE REPORT; CELL SUBPOPULATION; CLINICAL TRIAL (TOPIC); DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; ENDOTHELIUM; FEMALE; GENE DISRUPTION; HUMAN; LETTER; MALE; MONOCYTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TUMOR ASSOCIATED LEUKOCYTE;

EID: 84861793611     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-02-412551     Document Type: Letter

References (8)

1. Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116(16):e74-e80.
2. Wong KL, Yeap WH, Tai JJY, Ong SM, Dang TM, Wong SC. The three human monocytes subsets: implications for health and disease [published online ahead of print March 20, 2012]. Immunol Res. doi:10.1007/s12026-012-8297-3.
3. Saleh MN, Goldman SJ, LoBuglio AF, et al. CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. Blood. 1995;85(10):2910-2917.
4. Weiner LM, Li W, Holmes M, et al. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects. Cancer Res. 1994;54(15):4084-4090.
5. MacDonald KP, Palmer JS, Cronau S, et al. An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation. Blood. 2010;116(19):3955-3963.
6. Dai XM, Ryan GR, Hapel AJ, et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood. 2002;99(1):111-120.
7. Seitz M, Zwicker M, Loetscher P. Effects of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes. Arthritis Rheum. 1998;41(11):2032-2038.
8. Siedlar M, Strach M, Bukowska-Strakova K, et al. Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++ monocytes in common variable immunodeficiency (CVID) patients. Clin Immunol. 2011;139(2):122-132.